BAY-958, with the CAS number 1335490-39-5, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain biological pathways, which may contribute to its efficacy in treating specific diseases. The compound's structure typically includes functional groups that enhance its binding affinity to target proteins, thereby influencing cellular processes. BAY-958 has been studied for its role in modulating immune responses and may exhibit anti-inflammatory properties. As with many investigational drugs, its pharmacokinetics, toxicity, and overall safety profile are subjects of ongoing research. The compound's development is part of a broader effort to discover novel treatments for conditions that currently lack effective therapies. Further studies are necessary to fully elucidate its mechanism of action and therapeutic potential.

BAY-958 is a potent and selective PTEFb/CDK9 inhibitor.

BAY-958

1335490-39-5: BAY-958, with the CAS number 1335490-39-5, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain biological pathways, which may contribute to its efficacy in treating specific diseases. The compound's structure typically includes functional groups that enhance its binding affinity to target proteins, thereby influencing cellular processes. BAY-958 has been studied for its role in modulating immune responses and may exhibit anti-inflammatory properties. As with many investigational drugs, its pharmacokinetics, toxicity, and overall safety profile are subjects of ongoing research. The compound's development is part of a broader effort to discover novel treatments for conditions that currently lack effective therapies. Further studies are necessary to fully elucidate its mechanism of action and therapeutic potential.

<p>BAY-958 is a potent and selective inhibitor of PTEFb/CDK9.</p>

CAS 1335490-39-5

BAY-958

BAY-958

Ref: TM-T23775